Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study

Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of thrombosis and haemostasis 2022-11, Vol.20 (11), p.2601-2616
Hauptverfasser: Warkentin, Theodore E., Sheppard, Jo‐Ann I., Whitlock, Richard P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2616
container_issue 11
container_start_page 2601
container_title Journal of thrombosis and haemostasis
container_volume 20
creator Warkentin, Theodore E.
Sheppard, Jo‐Ann I.
Whitlock, Richard P.
description Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin. Objective To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed). Methods We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]). Results Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences. Conclusions Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.
doi_str_mv 10.1111/jth.15826
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9805231</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2727074023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS1ERUthwQsgS6yQOq0dj3_ColJVFVpUic2wthz7ZuJRJg620yo7Nt33GXkSXKatYIE3tu49_u65Ogi9o-SYlnOyyd0x5aoSL9AB5UwtpGLi5dO7ZmwfvU5pQwiteUVeoX3GlagVlQfobgXbMUTT4zFCgiGb7MOQcGhxB6OJfvj1894PbrLgcO5i2DbBzjmMMHiD29D34dYPa2xNdN5YnKa4hjh_wmc4lXoP5bstWIhHOEKOIY1gs78BbEMXYsYpT25-g_Za0yd4-3gfou-fL1bnl4vrb1-uzs-uF3a5ZGJRq0pWRjmomDHcNI4SEEKwpmU1503tbKtkTQmvuCNCKt5IS8GVtpPCMssO0emOO07NFtyDsbK6HqPfmjjrYLz-tzP4Tq_Dja5VgTJaAB8eATH8mCBlvQlTHIpnXaxJIpekYkX1caeyZd8UoX2eQIl-SEyXxPSfxIr2_d-WnpVPERXByU5w63uY_0_SX1eXO-Rvka2nIA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2727074023</pqid></control><display><type>article</type><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><creator>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</creator><creatorcontrib>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</creatorcontrib><description>Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin. Objective To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed). Methods We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]). Results Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences. Conclusions Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/jth.15826</identifier><identifier>PMID: 35869817</identifier><language>eng</language><publisher>England: Elsevier Limited</publisher><subject>Anticoagulants ; Anticoagulants - adverse effects ; Cardiac Surgical Procedures - adverse effects ; cardiopulmonary bypass ; Cohort analysis ; Heart ; Heart surgery ; Heparin ; Heparin - adverse effects ; Humans ; Immunization ; Original ; Patients ; platelet count ; PLATELETS ; Retrospective Studies ; Thrombocytopenia ; Thrombocytopenia - chemically induced ; Thrombocytopenia - complications ; Thrombocytopenia - diagnosis ; thrombosis</subject><ispartof>Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2601-2616</ispartof><rights>2022 The Authors. published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.</rights><rights>2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.</rights><rights>2022. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</citedby><cites>FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</cites><orcidid>0000-0002-4402-7809 ; 0000-0002-6863-5884 ; 0000-0002-8046-7588</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35869817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Warkentin, Theodore E.</creatorcontrib><creatorcontrib>Sheppard, Jo‐Ann I.</creatorcontrib><creatorcontrib>Whitlock, Richard P.</creatorcontrib><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><title>Journal of thrombosis and haemostasis</title><addtitle>J Thromb Haemost</addtitle><description>Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin. Objective To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed). Methods We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]). Results Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences. Conclusions Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</description><subject>Anticoagulants</subject><subject>Anticoagulants - adverse effects</subject><subject>Cardiac Surgical Procedures - adverse effects</subject><subject>cardiopulmonary bypass</subject><subject>Cohort analysis</subject><subject>Heart</subject><subject>Heart surgery</subject><subject>Heparin</subject><subject>Heparin - adverse effects</subject><subject>Humans</subject><subject>Immunization</subject><subject>Original</subject><subject>Patients</subject><subject>platelet count</subject><subject>PLATELETS</subject><subject>Retrospective Studies</subject><subject>Thrombocytopenia</subject><subject>Thrombocytopenia - chemically induced</subject><subject>Thrombocytopenia - complications</subject><subject>Thrombocytopenia - diagnosis</subject><subject>thrombosis</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS1ERUthwQsgS6yQOq0dj3_ColJVFVpUic2wthz7ZuJRJg620yo7Nt33GXkSXKatYIE3tu49_u65Ogi9o-SYlnOyyd0x5aoSL9AB5UwtpGLi5dO7ZmwfvU5pQwiteUVeoX3GlagVlQfobgXbMUTT4zFCgiGb7MOQcGhxB6OJfvj1894PbrLgcO5i2DbBzjmMMHiD29D34dYPa2xNdN5YnKa4hjh_wmc4lXoP5bstWIhHOEKOIY1gs78BbEMXYsYpT25-g_Za0yd4-3gfou-fL1bnl4vrb1-uzs-uF3a5ZGJRq0pWRjmomDHcNI4SEEKwpmU1503tbKtkTQmvuCNCKt5IS8GVtpPCMssO0emOO07NFtyDsbK6HqPfmjjrYLz-tzP4Tq_Dja5VgTJaAB8eATH8mCBlvQlTHIpnXaxJIpekYkX1caeyZd8UoX2eQIl-SEyXxPSfxIr2_d-WnpVPERXByU5w63uY_0_SX1eXO-Rvka2nIA</recordid><startdate>202211</startdate><enddate>202211</enddate><creator>Warkentin, Theodore E.</creator><creator>Sheppard, Jo‐Ann I.</creator><creator>Whitlock, Richard P.</creator><general>Elsevier Limited</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4402-7809</orcidid><orcidid>https://orcid.org/0000-0002-6863-5884</orcidid><orcidid>https://orcid.org/0000-0002-8046-7588</orcidid></search><sort><creationdate>202211</creationdate><title>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</title><author>Warkentin, Theodore E. ; Sheppard, Jo‐Ann I. ; Whitlock, Richard P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4436-98272a8de23aa5abd10e6663bf3955b9dcf87910525d06785b7c1edbf3d76c3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anticoagulants</topic><topic>Anticoagulants - adverse effects</topic><topic>Cardiac Surgical Procedures - adverse effects</topic><topic>cardiopulmonary bypass</topic><topic>Cohort analysis</topic><topic>Heart</topic><topic>Heart surgery</topic><topic>Heparin</topic><topic>Heparin - adverse effects</topic><topic>Humans</topic><topic>Immunization</topic><topic>Original</topic><topic>Patients</topic><topic>platelet count</topic><topic>PLATELETS</topic><topic>Retrospective Studies</topic><topic>Thrombocytopenia</topic><topic>Thrombocytopenia - chemically induced</topic><topic>Thrombocytopenia - complications</topic><topic>Thrombocytopenia - diagnosis</topic><topic>thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Warkentin, Theodore E.</creatorcontrib><creatorcontrib>Sheppard, Jo‐Ann I.</creatorcontrib><creatorcontrib>Whitlock, Richard P.</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of thrombosis and haemostasis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Warkentin, Theodore E.</au><au>Sheppard, Jo‐Ann I.</au><au>Whitlock, Richard P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study</atitle><jtitle>Journal of thrombosis and haemostasis</jtitle><addtitle>J Thromb Haemost</addtitle><date>2022-11</date><risdate>2022</risdate><volume>20</volume><issue>11</issue><spage>2601</spage><epage>2616</epage><pages>2601-2616</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Background Heparin‐induced thrombocytopenia (HIT) is an important adverse drug reaction that can occur postcardiac surgery. Preoperative exposure to unfractionated heparin (UFH) is common, raising the issue of how frequently cardiac surgery‐associated HIT occurs after immunizing preoperative exposure to heparin. Objective To determine the frequency and clinical picture of HIT occurring within 4 days of cardiac surgery (early presentation) versus later presentations (typical, delayed). Methods We identified patients with laboratory‐confirmed HIT following cardiac surgery over 30 years in a single cardiac surgery center. Three different clinical presentations of HIT were identified: typical (HIT‐related platelet count fall beginning between postoperative days [PODs] 5–10), delayed (patients with falls after POD10 or who presented following hospital discharge), and early (established before POD5, including during cardiac surgery [acute intraoperative HIT]). Results Of 129 patients identified with HIT complicating cardiac surgery, 100 had typical and 16 had delayed presentation of HIT; only 13 patients (10.1%) presented with early HIT, all of whom had received exposure to UFH during the 10 days before cardiac surgery. No patient was identified in whom remote preoperative UFH exposure was implicated in explaining early HIT. Notably, five patients appeared to have had acute intraoperative HIT, without immediate adverse consequences. Conclusions Approximately 90% of patients with HIT after cardiac surgery appear to develop this complication due to immunization triggered by cardiac surgery; however, in approximately 10% of patients, early presentation during the first four PODs (or intraoperatively) can be explained by recent immunizing exposure to heparin.</abstract><cop>England</cop><pub>Elsevier Limited</pub><pmid>35869817</pmid><doi>10.1111/jth.15826</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0002-4402-7809</orcidid><orcidid>https://orcid.org/0000-0002-6863-5884</orcidid><orcidid>https://orcid.org/0000-0002-8046-7588</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-7933
ispartof Journal of thrombosis and haemostasis, 2022-11, Vol.20 (11), p.2601-2616
issn 1538-7933
1538-7836
1538-7836
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9805231
source MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library
subjects Anticoagulants
Anticoagulants - adverse effects
Cardiac Surgical Procedures - adverse effects
cardiopulmonary bypass
Cohort analysis
Heart
Heart surgery
Heparin
Heparin - adverse effects
Humans
Immunization
Original
Patients
platelet count
PLATELETS
Retrospective Studies
Thrombocytopenia
Thrombocytopenia - chemically induced
Thrombocytopenia - complications
Thrombocytopenia - diagnosis
thrombosis
title Temporal presentations of heparin‐induced thrombocytopenia following cardiac surgery: A single‐center, retrospective cohort study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T21%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Temporal%20presentations%20of%20heparin%E2%80%90induced%20thrombocytopenia%20following%20cardiac%20surgery:%20A%20single%E2%80%90center,%20retrospective%20cohort%20study&rft.jtitle=Journal%20of%20thrombosis%20and%20haemostasis&rft.au=Warkentin,%20Theodore%20E.&rft.date=2022-11&rft.volume=20&rft.issue=11&rft.spage=2601&rft.epage=2616&rft.pages=2601-2616&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/jth.15826&rft_dat=%3Cproquest_pubme%3E2727074023%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2727074023&rft_id=info:pmid/35869817&rfr_iscdi=true